$GHDX GENOMIC HEALTH INC Insider Trading Week 47/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENOMIC HEALTH INC in week 47/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 77,976 | 5,989,017 | 10,319,430 | 10.4 M to 10.3 M (-0.75 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 11,972 | 919,520 | 1,618,548 | 1.6 M to 1.6 M (-0.73 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 2,064 | 158,527 | 312,447 | 314.5 K to 312.4 K (-0.66 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 1,197 | 91,937 | 198,181 | 199.4 K to 198.2 K (-0.60 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 91 | 6,989 | 52,429 | 52.5 K to 52.4 K (-0.17 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 1,335 | 102,536 | 216,569 | 217.9 K to 216.6 K (-0.61 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 13,595 | 1,006,150 | 10,397,406 | 10.4 M to 10.4 M (-0.13 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 2,087 | 154,456 | 1,630,520 | 1.6 M to 1.6 M (-0.13 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 360 | 26,643 | 314,511 | 314.9 K to 314.5 K (-0.11 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 209 | 15,468 | 199,378 | 199.6 K to 199.4 K (-0.10 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 16 | 1,184 | 52,520 | 52.5 K to 52.5 K (-0.03 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 233 | 17,244 | 217,904 | 218.1 K to 217.9 K (-0.11 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 57,979 | 4,331,524 | 10,411,001 | 10.5 M to 10.4 M (-0.55 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 8,901 | 664,980 | 1,632,607 | 1.6 M to 1.6 M (-0.54 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 1,534 | 114,603 | 314,871 | 316.4 K to 314.9 K (-0.48 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 890 | 66,491 | 199,587 | 200.5 K to 199.6 K (-0.44 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 68 | 5,080 | 52,536 | 52.6 K to 52.5 K (-0.13 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 994 | 74,260 | 218,137 | 219.1 K to 218.1 K (-0.45 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 56,764 | 4,272,831 | 10,468,980 | 10.5 M to 10.5 M (-0.54 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 8,715 | 656,009 | 1,641,508 | 1.7 M to 1.6 M (-0.53 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 1,502 | 113,061 | 316,405 | 317.9 K to 316.4 K (-0.47 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 871 | 65,563 | 200,477 | 201.3 K to 200.5 K (-0.43 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 66 | 4,968 | 52,604 | 52.7 K to 52.6 K (-0.13 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 973 | 73,241 | 219,131 | 220.1 K to 219.1 K (-0.44 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 36,652 | 2,703,294 | 10,525,744 | 10.6 M to 10.5 M (-0.35 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 5,627 | 415,023 | 1,650,223 | 1.7 M to 1.7 M (-0.34 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 970 | 71,543 | 317,907 | 318.9 K to 317.9 K (-0.30 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 563 | 41,524 | 201,348 | 201.9 K to 201.3 K (-0.28 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 43 | 3,171 | 52,670 | 52.7 K to 52.7 K (-0.08 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 628 | 46,319 | 220,104 | 220.7 K to 220.1 K (-0.28 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 77,558 | 5,758,092 | 10,562,396 | 10.6 M to 10.6 M (-0.73 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 11,907 | 884,004 | 1,655,850 | 1.7 M to 1.7 M (-0.71 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 2,052 | 152,345 | 318,877 | 320.9 K to 318.9 K (-0.64 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 1,190 | 88,348 | 201,911 | 203.1 K to 201.9 K (-0.59 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 91 | 6,756 | 52,713 | 52.8 K to 52.7 K (-0.17 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 1,329 | 98,668 | 220,732 | 222.1 K to 220.7 K (-0.60 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 8,204 | 607,484 | 10,639,954 | 10.6 M to 10.6 M (-0.08 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 1,260 | 93,300 | 1,667,757 | 1.7 M to 1.7 M (-0.08 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 217 | 16,068 | 320,929 | 321.1 K to 320.9 K (-0.07 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 126 | 9,330 | 203,101 | 203.2 K to 203.1 K (-0.06 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 10 | 740 | 52,804 | 52.8 K to 52.8 K (-0.02 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 141 | 10,441 | 222,061 | 222.2 K to 222.1 K (-0.06 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 24,487 | 1,820,848 | 10,648,158 | 10.7 M to 10.6 M (-0.23 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 3,759 | 279,518 | 1,669,017 | 1.7 M to 1.7 M (-0.22 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 648 | 48,185 | 321,146 | 321.8 K to 321.1 K (-0.20 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 376 | 27,959 | 203,227 | 203.6 K to 203.2 K (-0.18 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 28 | 2,082 | 52,814 | 52.8 K to 52.8 K (-0.05 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 419 | 31,157 | 222,202 | 222.6 K to 222.2 K (-0.19 %) |